| Body na spoluautora | Body za publikaci pro MU | Odkaz ISVaV | | 4,33 | 30,31 | Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis
|
| 6,37 | 31,83 | Genetic variations and plasma levels of the Gelatinase A (matrix metalloproteinase-2) and Gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy
|
| 1,40 | 5,62 | Vliv dlouhodobé substituční terapie růstovým hormonem na tělesné složení, kostní tkáň a některé metabolické parametry u dospělých osob s deficitem růstového hormonu
|
| 5,93 | 47,47 | Genetic variations in the human gelatinase A (MMP-2) promoter are not associated with susceptibility to, and severity of, chronic periodontitis
|
| 0,31 | 2,81 | Identifikace genetických rizikových faktor diabetické nefropatie u T2DM v genech pro EDN1, LTA, RAGE a NOS3 pomocí multilokusové analýzy
|
| 2,77 | 19,41 | Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis
|
| 2,12 | 10,58 | Genetic variation and plasma level of the basic fibroblast growth factor in proliferative diabetic retinopathy
|
| 7,18 | 64,58 | Genetic risk factors for diabetic nephropathy on chromosomes 6p and 7q identified by the set-association approach
|
| 0,00 | 0,00 | Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes polymorphisms in multiple sclerosis.
|
| 8,75 | 52,48 | Matrix metalloproteinase-9 gene polymorphisms in multiple sclerosis
|
Back
(c) Michal Bulant, 2011